IL6 and Parkinson disease: In a 1-methyl-4-phenylpyridinium-induced mouse model of PD, donepezil treatment modulates proinflammatory cytokine levels (IL-6, IL-1β, and TNF-α) via inhibition of M1 polarization [49].